In metastatic tumors, site-specific hypomethylation was associated with reactivation of a cryptic transcript of TBC1 Domain Family Member 16 (TBC1D16) and poor clinical outcome [15]. This evidence concerns the gene TBC1D16 and metastatic neoplasm.